#EBW25 Editorial: How Miltenyi Biotec is driving reproducibility and innovation in biobanking

This article has 245  words and is a 1-minute read.

The Europe Biobank Week Congress highlights the latest trends and important topics in biobanking and biomolecular resources. It brings together professionals, patients, and government representatives to exchange ideas and learn from one another. Over four days, attendees can enjoy keynote speeches, join discussions, network, and explore exhibits showcasing new technologies and products.

We’ve spoken with all our sponsors for 2025 to understand why they value being part of the year’s key in-person event for the global biobanking community. Here’s what Miltenyi Biotec had to say.

Company description

For more than 35 years, Miltenyi Biotec has been developing and providing advanced solutions for scientific research, regenerative medicine, gene and cell therapy to promote the advancement of biomedical research. Founded in 1989 by Stefan Miltenyi, the company has established itself as a major global player in the field of applied biotechnology and cell biology. The company is renowned for designing and manufacturing highly specialised instrumentation and reagents used in research laboratories, hospitals and clinics, which are always innovative and cutting-edge, as in the case of technologies released in the fields of cytometry, spatial biology and manufacturing of cell therapies in GMP environments. 

Why does it matter to be at EBW25? 

Being at EBW25 is important to us because it allows Miltenyi Biotec to be recognized as a dedicated partner in biobanking activities.

What new innovation are you bringing or what are you most looking forward to? 

We bring smart solutions to achieve more and more reproducible results.